Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Colorectal Neoplasms 112Breast Neoplasms 87Carcinoma, Non-Small-Cell Lung 85Glioblastoma 72Ovarian Neoplasms 62Brain Neoplasms 45Lung Neoplasms 41Glioma 41Fallopian Tube Neoplasms 41Neoplasms 38Colonic Neoplasms 34Gliosarcoma 33Carcinoma, Renal Cell 32Rectal Neoplasms 31Neoplasm Metastasis 29Pancreatic Neoplasms 19Carcinoma, Hepatocellular 19Melanoma 18Adenocarcinoma of Lung 18Astrocytoma 15Kidney Neoplasms 13Stomach Neoplasms 12Prostatic Neoplasms 12Uterine Cervical Neoplasms 11Oligodendroglioma 11Liver Neoplasms 11Esophageal Neoplasms 11Sarcoma 10Adenocarcinoma, Bronchiolo-Alveolar 10Central Nervous System Neoplasms 9

Interventions

Cyclophosphamide 21fludarabine phosphate 18Whole-Body Irradiation 17Methotrexate 17Tacrolimus 15Peripheral Blood Stem Cell Transplantation 15Mycophenolic Acid 13Dexamethasone 11Vincristine 10Etoposide 10Antilymphocyte Serum 10Calcium Dobesilate 9Busulfan 9Rituximab 8Doxorubicin 8merphos 7Filgrastim 7Cytarabine 7Sirolimus 6Prednisone 6Melphalan 6Granulocyte Colony-Stimulating Factor 6Cyclosporine 6pegaspargase 5dexamethasone acetate 5dexamethasone 21-phosphate 5prednylidene 4deltacortene 4auricularum 4Radiotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Bevacizumab × Clear all
NCT00217425 2023-06-18

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

Eastern Cooperative Oncology Group

Phase 2 Completed
46 enrolled 7 charts
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡